According to the result of Western blot analysis (Figure 3A), human breast cancer cell line MDA-MB-468 with the highest expression level of legumain was chosen as the legumain-positive tumor cell model, and human prostate cancer cell PC-3 with the lowest expression level of legumain was chosen as the legumain-negative tumor cell model. This evidence concerns the gene LGMN and prostate carcinoma.